Article

Cross-sectional analysis of Open payments for physicians at designated hemophilia centers in the US (2018-2020)

2023-03-09

Abstract excerpt

<h4>Introduction</h4> Physicians who treat hemophilia, and especially directors at hemophilia centers, are in a position to be unduly influenced by payments from pharmaceutical companies who make costly hemophilia drugs. It is from this perspective that we analyzed payments made to physicians at hemophilia centers in the US, focusing on center directors. <h4>Materials and methods</h4> In a cross-sectional analysis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8773258f-f850-5ba2-91f5-ef8a2a03a192
DOI: 10.1101/2023.03.07.23286934

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cross-sectional analysis of Open payments for physicians at designated hemophilia centers in the US (2018-2020)DOI 10.1101/2023.03.07.23286934Read

Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021Semantic proximity Read

Financial Conflicts of Interest among U.S. Physician Authors of 2020 Clinical Practice Guidelines: A Cross-Sectional StudySemantic proximity Read

Industry payments to anesthesiologists in the United States between 2014 and 2022Semantic proximity Read

Behind the Paywall: Unreported Financial Conflicts in Eminent Psychiatry JournalsSemantic proximity Read

A Cross-Sectional Examination of Conflict-of-Interest Disclosures of Physician-Authors Publishing in High-Impact US Medical JournalsSemantic proximity Read

Rare Disease Curative Care Expenditure- Financing Scheme-Health Provider- Beneficiary Group Analysis — An Empirical Study in Sichuan Province, ChinaSemantic proximity Read

Trends in Industry-Sponsored Research Funding to Orthopaedic Surgeons in the U.S. from 2017-2024Semantic proximity Read

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019Semantic proximity Read

Nature and Trends of Pharmaceutical Payments to the Board Certified Respiratory Specialists in Japan between 2016 and 2019Semantic proximity Read

Characterizing industry payments to ophthalmologists before and after onset of the COVID-19 pandemicSemantic proximity Read

Financial conflicts of interest among authors of clinical practice guideline for headache disorders and board-certified neurologists in JapanSemantic proximity Read

The Amortization of Funding Gene Therapies: Making the “Intangibles” Tangible for PatientsSemantic proximity Read